A new data-driven tool will help state and county decisionmakers in the U.S. plan for the distribution of coronavirus vaccines to priority populations.
The odds are “reasonably high” that a coronavirus vaccine will be approved before the end of the year, according to Harvard Chan School's Howard Koh.
An op-ed co-authored by Dean Michelle Williams addresses the issue of race and vaccine allocation in the U.S.
Howard Koh of Harvard Chan School outlined five ways for political leaders to build trust in a coronavirus vaccine.
Quick updates about the latest public health news from across the School and beyond.
The COVID-19 pandemic has inspired new research directions across the School
Rates of vaccination for the human papillomavirus are on the rise among children in the U.S., but still fall short of national goals.
Harvard Chan School's Barry Bloom discusses the coronavirus vaccine development process and how to persuade people to get vaccinated.
Research fellow Stephen Kissler discussed the past six months of coronavirus response in Massachusetts as well as what to expect in the next six.
Positive early trial results from two coronavirus vaccine candidates are “very exciting,” according to Harvard Chan School's Barry Bloom.